Department of Integrative Biology and Physiology
DeWayne Townsend has not added Biography.
If you are DeWayne Townsend and would like to personalize this page please email our Author Liaison for assistance.
Predominance of delta-opioid-binding sites in the porcine enteric nervous system.
The Journal of pharmacology and experimental therapeutics Mar, 2002 | Pubmed ID: 11861796
Cannabinoids throw up a conundrum.
British journal of pharmacology Nov, 2002 | Pubmed ID: 12381670
Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine.
The Journal of pharmacology and experimental therapeutics Jan, 2004 | Pubmed ID: 14569065
Characterization of specific delta-opioid binding sites in the distal small intestine of swine.
European journal of pharmacology Dec, 2003 | Pubmed ID: 14660011
Dystrophic heart failure blocked by membrane sealant poloxamer.
Nature Aug, 2005 | Pubmed ID: 16025101
Mediation of neurogenic ion transport by acetylcholine, prostanoids and 5-hydroxytryptamine in porcine ileum.
European journal of pharmacology Sep, 2005 | Pubmed ID: 16135363
Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach.
Expert review of cardiovascular therapy Jan, 2007 | Pubmed ID: 17187461
Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Jul, 2007 | Pubmed ID: 17360850
Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure.
Molecular therapy : the journal of the American Society of Gene Therapy Jun, 2007 | Pubmed ID: 17440445
Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle.
Molecular therapy : the journal of the American Society of Gene Therapy May, 2008 | Pubmed ID: 18414480
Designing heart performance by gene transfer.
Physiological reviews Oct, 2008 | Pubmed ID: 18923190
Artificial selection for whole animal low intrinsic aerobic capacity co-segregates with hypoxia-induced cardiac pump failure.
PloS one , 2009 | Pubmed ID: 19568432
Cardiac consequences to skeletal muscle-centric therapeutics for Duchenne muscular dystrophy.
Trends in cardiovascular medicine Feb, 2009 | Pubmed ID: 19577712
Molecular cardiology in translation: gene, cell and chemical-based experimental therapeutics for the failing heart.
Journal of cardiovascular translational research Dec, 2008 | Pubmed ID: 19956787
Heparan sulfate Ndst1 regulates vascular smooth muscle cell proliferation, vessel size and vascular remodeling.
Journal of molecular and cellular cardiology Aug, 2010 | Pubmed ID: 20206635
Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs.
The Journal of clinical investigation Apr, 2010 | Pubmed ID: 20234088
Distinct pathophysiological mechanisms of cardiomyopathy in hearts lacking dystrophin or the sarcoglycan complex.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Sep, 2011 | Pubmed ID: 21665956
Age-dependent dystrophin loss and genetic reconstitution establish a molecular link between dystrophin and heart performance during aging.
Molecular therapy : the journal of the American Society of Gene Therapy Oct, 2011 | Pubmed ID: 21730971
Cardiac involvement in the dystrophinopathies.
Journal of pediatric rehabilitation medicine , 2008 | Pubmed ID: 21791770
Exercise and muscular dystrophy: implications and analysis of effects on musculoskeletal and cardiovascular systems.
Comprehensive Physiology Jul, 2011 | Pubmed ID: 23733645
Alterations of dystrophin-associated glycoproteins in the heart lacking dystrophin or dystrophin and utrophin.
Journal of muscle research and cell motility Dec, 2013 | Pubmed ID: 24096570
Finding the sweet spot: assembly and glycosylation of the dystrophin-associated glycoprotein complex.
Anatomical record (Hoboken, N.J. : 2007) Sep, 2014 | Pubmed ID: 25125182
Dystrobrevin increases dystrophin's binding to the dystrophin-glycoprotein complex and provides protection during cardiac stress.
Journal of molecular and cellular cardiology Nov, 2014 | Pubmed ID: 25158611
Early right ventricular fibrosis and reduction in biventricular cardiac reserve in the dystrophin-deficient mdx heart.
American journal of physiology. Heart and circulatory physiology Feb, 2015 | Pubmed ID: 25485898
Severe dystrophic cardiomyopathy caused by the enteroviral protease 2A-mediated C-terminal dystrophin cleavage fragment.
Science translational medicine Jul, 2015 | Pubmed ID: 26136477
Early Detection of Myocardial Bioenergetic Deficits: A 9.4 Tesla Complete Non Invasive 31P MR Spectroscopy Study in Mice with Muscular Dystrophy.
PloS one , 2015 | Pubmed ID: 26262993
Diastolic dysfunction precedes hypoxia-induced mortality in dystrophic mice.
Physiological reports Aug, 2015 | Pubmed ID: 26311833
Hypoxia-induced cardiac injury in dystrophic mice.
American journal of physiology. Heart and circulatory physiology Apr, 2016 | Pubmed ID: 26851247
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유